Physician profile
Daniel E Greenblatt
NPI 1962638965
$2,278.20
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $449 · 2020: $606 · 2021: $688 · 2022: $374 · 2023: $161.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $161.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $161.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $408.56 | 2019-2023 | Jornay Pm |
| Tris Pharma INC | $391.55 | 2020-2022 | |
| Neurelis, INC. | $381.25 | 2020-2023 | Valtoco |
| Supernus Pharmaceuticals, INC. | $279.18 | 2019-2023 | Qelbree |
| Eisai INC. | $141.65 | 2019-2022 | |
| Ucb, INC. | $131.42 | 2021-2023 | Briviact |
| Livanova USA, INC. | $106.42 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $99.31 | 2019-2020 | |
| Corium, LLC | $89.89 | 2022 | |
| Vertical Pharmaceuticals, LLC | $54.61 | 2019-2020 | |
| Biogen, INC. | $37.97 | 2019-2021 | |
| Jazz Pharmaceuticals INC. | $24.79 | 2020 | |
| Greenwich Biosciences, INC. | $23.32 | 2020 | |
| Azurity Pharmaceuticals, INC. | $22.48 | 2023 | Eprontia |
| Shire North American Group INC | $18.79 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zogenix INC. | $16.40 | 2021 | |
| Astrazeneca Pharmaceuticals Lp | $13.52 | 2020 | |
| Biomarin Pharmaceutical INC. | $13.01 | 2023 | Brineura |
| Adlon Therapeutics L.P. | $12.08 | 2021 | |
| Alexion Pharmaceuticals, INC. | $12.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Greenblatt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.